EQUITY RESEARCH MEMO

Renaissance

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)60/100

Renaissance Lakewood, LLC is a US-based contract development and manufacturing organization (CDMO) specializing in complex nasal spray and sterile injectable dosage forms. Founded in 2020 and headquartered in New York, the company offers a comprehensive 'bench-to-shelf' service encompassing R&D, analytical testing, aseptic fill-finish, and packaging. Its focus on niche delivery systems positions it as a strategic partner for pharmaceutical clients seeking expertise in nasal drug delivery and sterile liquid manufacturing. Despite being early-stage, Renaissance has achieved approval status, indicating its facilities and processes meet regulatory standards. The CDMO market for nasal sprays and injectables is growing, driven by demand for biologics and self-administered therapies, providing Renaissance with opportunities to capitalize on outsourcing trends.

Upcoming Catalysts (preview)

  • Q4 2026New Client Contract for Nasal Spray Development65% success
  • Q3 2026Facility Expansion to Increase Aseptic Fill-Finish Capacity70% success
  • Q4 2026Strategic Partnership with a Mid-Size Pharma for Sterile Injectables55% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)